Cardiogenesis Corp., an Irvine medical device maker, is being bought for $22 million by Georgia’s CryoLife Inc. Cardiogenesis, which had sales of $11.3 million last year, makes devices used to treat ...

The "US Market Report for Transmyocardial Revascularization Devices 2018 - MedCore" report has been added to Research and Markets' offering. Many patients with severe angina experience inadequate ...

Transmyocardial laser revascularization is an alternative treatment option for patients with refractory angina who are not suitable candidates for more conventional coronary intervention or surgery.

Dr. Keith Roach writes a medical question-and-answer column weekdays. Dear Dr. Roach: There once was what I thought was a terrific procedure to increase blood flow to the myocardium — transmyocardial ...

Dr. Ian Hardy, a prominent medical innovator, patented the Transmyocardial Revascularization technique in 1985 (Patent #4,658,817 Method and Apparatus for Transmyocardial Revascularization Using a ...

PLC Systems Inc. (OTC:PLCSF) entered into a deal to sell off its transmyocardial revascularization assets to Novadaq Technologies Inc. (TSX:NDQ) for $1 million in cash. The transaction could be worth ...

Franklin-based medical device company PLC Systems Inc. had a net loss of $3.8 million in the first quarter of 2011, compared to $561,000 in the same period last year, as it absorbed costs related to a ...

Current research utilizes the laser technology and the TMLR theory and applies them to a less invasive endovascular approach. PTMR is performed in the cardiac catheterization laboratory, and the laser ...